|1.||Bergman, A: 1 article (11/2000)|
|2.||Magnusson, A: 1 article (11/2000)|
|1.||Liver Diseases (Liver Disease)
|2.||Experimental Liver Cirrhosis
09/01/1998 - "The efficacy of FP 736-04 in experimental liver cirrhosis."
05/01/1997 - "The uptake of FP 736-04 by the fatty liver was significantly reduced, yielding a maximum enhancement of 22.3 +/- 7.9 HU as compared to a value of 32.3 +/- 5.0 HU in the control group. "
05/01/1997 - "CT with the hepatocyte-specific contrast medium FP 736-04 in an experimental model of liver steatosis."
01/01/1997 - "In cases of fatty liver infiltration, enhancement by FP 736-04 was significantly reduced as compared with normal controls. "
11/01/2000 - "A pre-examination period of starvation had no effect on FP 736-04 liver enhancement on CT However, liver attenuation tended to decrease more slowly in the starvation group than in the controls."
11/01/2000 - "A control group was subjected to the same CT examination protocol with use of FP 736-04 but without prior starvation. "
11/01/2000 - "To investigate the effect of starvation on contrast-enhanced CT of the liver using the iodinated hepatocyte-specific lipid emulsion FP 736-04. "
11/01/2000 - "Influence of pre-examination starvation on liver uptake of the hepatocyte-specific contrast medium FP 736-04 at CT. "
|5.||Neoplasm Metastasis (Metastasis)